These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27492832)

  • 81. Lung-resident eosinophils represent a distinct regulatory eosinophil subset.
    Mesnil C; Raulier S; Paulissen G; Xiao X; Birrell MA; Pirottin D; Janss T; Starkl P; Ramery E; Henket M; Schleich FN; Radermecker M; Thielemans K; Gillet L; Thiry M; Belvisi MG; Louis R; Desmet C; Marichal T; Bureau F
    J Clin Invest; 2016 Sep; 126(9):3279-95. PubMed ID: 27548519
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The clinical profile of benralizumab in the management of severe eosinophilic asthma.
    Menzella F; Lusuardi M; Galeone C; Facciolongo N; Zucchi L
    Ther Adv Respir Dis; 2016 Dec; 10(6):534-548. PubMed ID: 27612492
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Atopy and Inhaled Corticosteroid Use Associate with Fewer IL-17+ Cells in Asthmatic Airways.
    Fattahi F; Brandsma CA; Lodewijk M; Reinders-Luinge M; Postma DS; Timens W; Hylkema MN; Ten Hacken NH
    PLoS One; 2016; 11(8):e0161433. PubMed ID: 27552197
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial.
    Anderson JR; Mortimer K; Pang L; Smith KM; Bailey H; Hodgson DB; Shaw DE; Knox AJ; Harrison TW
    PLoS One; 2016; 11(8):e0160257. PubMed ID: 27560168
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience.
    Caminati M; Senna G; Stefanizzi G; Bellamoli R; Longhi S; Chieco-Bianchi F; Guarnieri G; Tognella S; Olivieri M; Micheletto C; Festi G; Bertocco E; Mazza M; Rossi A; Vianello A;
    BMC Pulm Med; 2016 Aug; 16(1):128. PubMed ID: 27562427
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study.
    Houben-Wilke S; Jörres RA; Bals R; Franssen FM; Gläser S; Holle R; Karch A; Koch A; Magnussen H; Obst A; Schulz H; Spruit MA; Wacker ME; Welte T; Wouters EF; Vogelmeier C; Watz H
    Am J Respir Crit Care Med; 2017 Jan; 195(2):189-197. PubMed ID: 27532739
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Real-life effect of long-acting β
    Jabbal S; Manoharan A; Anderson W; Lipworth J; Lipworth B
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):430-431. PubMed ID: 27519578
    [No Abstract]   [Full Text] [Related]  

  • 88. Simultaneously elevated exhaled nitric oxide and serum-eosinophil cationic protein relate to recent asthma events in asthmatics in a cross-sectional population-based study.
    Mogensen I; Alving K; Bjerg A; Borres MP; Hedlin G; Sommar J; Dahlén SE; Janson C; Malinovschi A
    Clin Exp Allergy; 2016 Dec; 46(12):1540-1548. PubMed ID: 27513280
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study).
    Niven RM; Saralaya D; Chaudhuri R; Masoli M; Clifton I; Mansur AH; Hacking V; McLain-Smith S; Menzies-Gow A
    BMJ Open; 2016 Aug; 6(8):e011857. PubMed ID: 27507234
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Randomized Trial of Once-Daily Fluticasone Furoate in Children with Inadequately Controlled Asthma.
    Oliver AJ; Covar RA; Goldfrad CH; Klein RM; Pedersen SE; Sorkness CA; Tomkins SA; Villarán C; Grigg J
    J Pediatr; 2016 Nov; 178():246-253.e2. PubMed ID: 27622699
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study.
    Kole TM; Muiser S; Kraft M; Siddiqui S; Fabbri LM; Rabe KF; Papi A; Brightling C; Singh D; van der Molen T; Nawijn MC; Kerstjens HAM; van den Berge M
    BMJ Open Respir Res; 2024 Jun; 11(1):. PubMed ID: 38901877
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Next-Generation Therapeutic Approaches for Uncontrolled Asthma: Insights Into the Heterogeneity of Non-Type 2 Inflammation.
    Kim SR
    Allergy Asthma Immunol Res; 2024 Jan; 16(1):1-5. PubMed ID: 38262386
    [No Abstract]   [Full Text] [Related]  

  • 93. Proteomic signatures of eosinophilic and neutrophilic asthma from serum and sputum.
    Asamoah K; Chung KF; Zounemat Kermani N; Bodinier B; Dahlen SE; Djukanovic R; Bhavsar PK; Adcock IM; Vuckovic D; Chadeau-Hyam M;
    EBioMedicine; 2024 Jan; 99():104936. PubMed ID: 38128411
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Deterioration of lung function and its association with eosinophil count.
    Rajanayagam B; Manikandan S; Anand N
    Bioinformation; 2023; 19(5):644-648. PubMed ID: 37886149
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Phenotype overlap in the natural history of asthma.
    Ricciardolo FLM; Guida G; Bertolini F; Di Stefano A; Carriero V
    Eur Respir Rev; 2023 Jun; 32(168):. PubMed ID: 37197769
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Delineating asthma according to inflammation phenotypes with a focus on paucigranulocytic asthma.
    Feng Y; Liu X; Wang Y; Du R; Mao H
    Chin Med J (Engl); 2023 Jul; 136(13):1513-1522. PubMed ID: 37185590
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Peripheral Blood Counts in Asthma Control: Is it Relevant?
    Agarwal S; Jat KR
    Indian J Pediatr; 2023 Jun; 90(6):535-536. PubMed ID: 36869276
    [No Abstract]   [Full Text] [Related]  

  • 98. Comparison between clinical trials and real-world evidence studies on biologics for severe asthma.
    Menzella F; Ballarin A; Sartor M; Floriani AF; Corsi L; Dartora C; Tonin S; Romagnoli M
    J Int Med Res; 2022 Nov; 50(11):3000605221133689. PubMed ID: 36420737
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Selected hematological abnormalities and their associated factors among asthmatic patients in Northwest Ethiopia: a cross-sectional study.
    Solomon Y; Woldu B; Mesfin N; Enawgaw B
    BMC Pulm Med; 2022 Jun; 22(1):228. PubMed ID: 35698065
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Genome-Wide Association Study of Fluorescent Oxidation Products Accounting for Tobacco Smoking Status in Adults from the French EGEA Study.
    Orsi L; Margaritte-Jeannin P; Andrianjafimasy M; Dumas O; Mohamdi H; Bouzigon E; Demenais F; Matran R; Zerimech F; Nadif R; Dizier MH
    Antioxidants (Basel); 2022 Apr; 11(5):. PubMed ID: 35624665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.